Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome

  • Protocol
  • Intervention

Authors

  • Nienke S Weiss,

    1. Spaarne Hospital, Hoofddorp, Obstetrics and Gynaecology, Amsterdam, Netherlands
    Search for more papers by this author
  • Marleen Nahuis,

    1. Academic Medical Centre, University of Amsterdam, Obstetrics and Gynaecology, Amsterdam, Netherlands
    Search for more papers by this author
  • Neriman Bayram,

    1. Zaans Medisch Centrum, Department of Obstetrics and Gynaecology, Zaandam, Netherlands
    Search for more papers by this author
  • Ben Willem J Mol,

    1. Academic Medical Centre, University of Amsterdam, Obstetrics and Gynaecology, Amsterdam, Netherlands
    Search for more papers by this author
  • Fulco Van der Veen,

    1. Academic Medical Centre, University of Amsterdam, Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands
    Search for more papers by this author
  • Madelon van Wely

    Corresponding author
    1. Academic Medical Centre, University of Amsterdam, Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology, Amsterdam, Netherlands
    • Madelon van Wely, Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology, Academic Medical Centre, University of Amsterdam, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, Netherlands. m.vanwely@amc.uva.nl.

    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effectiveness and safety of all gonadotrophins (urinary and recombinant) for ovulation induction in women with PCOS.